Markets & Finance

Movers: ICE, Molson Coors, Amgen, VeriFone


Plus more stocks making market headlines on Thursday

From Standard & Poor's Equity ResearchIntercontinentalExchange (ICE)

Up 0.54 to 149.52

Resubmits merger proposal to CHICAGO BOARD OF TRADE, with number of enhancements... Based on 6/12 closing prices, ICE offer is valued at $211.55 per BOT share; holders can elect to receive cash in lieu of stock.

Molson Coors (TAP)

Up 4.13 to 93.73

UBS Financial upgrades to buy from neutral.

Amgen (AMGN)

Down 0.11 to 57.35

Co., unit of WYETH announce presentation of additional data showing safety profile of Enbrel was maintained with LT use in patients with moderate-to-severe juvenile rheumatoid arthritis who completed up to 8 years of therapy.

Verifone Holding (PAY)

Up 1.90 to 34.56

The company says it has been selected as sole provider of electronic payment systems by China Postal Savings Bank.

Schulman (A.) (SHLM)

Down 2.16 to 21.80

Sees fiscal 07 net income of $17M-$23M, below previous guidance of $25M-$30M... Cites unexpected continued weakness in both Europe and North America during third quarter... Keybanc downgrades to hold.

United Community (UCBI)

Down 1.84 to 27.44

The company says it monitoring impact of halted real estate development in North Carolina... The company says it cannot at this time quantify its likely loss related to these loans or the extent to which such loss may be covered by insurance.

ARM Holdings ADS (ARMHY)

Up 0.36 to 8.27

JP Morgan upgrades to overweight from underweight.

La Jolla Pharmac (LJPC)

Down 0.28 to 4.93

Lazard reportedly initiates coverage with sell.

Lawson Software (LWSN)

Up 0.73 to 10.06

Sees better-than-expected $37M-$40M Q4 software license revs... Cites larger volume of signed deals, Q4 seasonality, improved sales productivity, increased license revenues for Lawson System Foundation product.

Sapient (SAPE)

Up 0.65 to 8.19

Posted 7 cents vs. 3 cents first quarter non-GAAP EPS from cont. ops on 39% revenue rise... Sees second quarter service revs of more than $126M, non-GAAP operating margins are expected to be in excess of 7%... RBC Capital ups to outperform... See Pg. 5

Oculus Innovative (OCLS)

Up 0.57 to 7.81

Grants exclusive 10-yr worldwide license to Drug Enhancement the company of America for Microcyn Technology for use in OTC 1st responder pen-like applicator... Deal could provide minimum payments of up to $47.5M to OCLS.

Caraustar Indus (CSAR)

Up 0.70 to 5.88

UBS Financial upgrades to neutral from reduce.

TTM Technologies (TTMI)

Up 0.82 to 11.97

Bear Stearns upgrades to outperform from underperform.

Vasco Data Secur (VDSI)

Up 1.59 to 23.18

Friedman Billings reportedly upgrades to outperform from market perform.

Saba Software (SABA)

Down 0.26 to 5.25

Expects $25.2M-$26M Q4 total GAAP rev, 9 cents-$0.12 loss, vs. previous guidance of $27.5M-$29.5M rev, breakeven to 5 cents GAAP EPS... Notes continued biz model shift, certain contractual contingencies.

HealthSpring (HS)

Down 4.16 to 18.70

Cuts 2007 EPS guidance to $1.20-$1.35... The company says adverse medical cost trends reported in first quarter continued in April, May... Estimates second quarter Medicare Advantage medical loss ratio (MLR) will be in range of 82.5%-83.5%.

Las Vegas Sands (LVS)

Up 0.52 to 78.90

Announces The Venetian Macao Resort Hotel will open on Aug. 28, 2007.

Lifecell Corp (LIFC)

Up 0.95 to 29.24

Receives 510(k) clearance from FDA for Strattice tissue matrix, which intended for use in soft tissue repair procedures incl. breast reconstruction, hernia repair.

Pharmacopeia (PCOP)

Up 0.11 to 5.80

To receive $5M payment from GLAXOSMITHKLINE... This is second $5M payment in connection with product development, commercialization deal entered into by two cos in March 2006.

Pharmacopeia Inc (WCC)

Up 1.66 to 64.33

UBS Financial upgrades to buy from neutral, citing recovery in copper prices, potential recovery in industrial activity, continued growth in non-residential construction markets.


China's Killer Profits
LIMITED-TIME OFFER SUBSCRIBE NOW

Sponsored Financial Commentaries

Sponsored Links

Buy a link now!

 
blog comments powered by Disqus